2009.03.05 Weekly Broadcast Email
The following updates were made the website for the week of March 2, 2009.
97405 (Randomized Study of Soy Protein and Effexor on Vasomotor Symptoms of Men with Prostate Cancer)
Since the closure of the COLD-fX, is your site looking for a new study? Then consider enrolling patients in the Soy/Effexor trial.
Mark your calendars for a conference call with the CCCWFU CCOP Research Base on Monday, March 9, 2009 at 10:30am EST. The purpose of this call is to answer questions about the protocol in general, review the soy powder usage, discuss patient recruitment, and encourage interested sites to open this study.
The call in information is as follows:
Call in number: 1-877-339-0018
Meeting #: *7605195* (stars must be dialed)
Our goal is to have 127 patients registered by June 1st. Click here to download the protocol documents, view slide show presentations, learn about upcoming conference calls and more. Consider joining the Research Base in reaching its June 1st goal!
To all CCOP Administrators: We need to receive the annual report form that was forwarded to you a couple weeks ago. If this form has not been submitted, please complete the form, (another copy is attached) and return to Lisa Hawkins at email@example.com by 5pm tomorrow, March 6, 2009. We need this information for our Progress Report for NCI. – Thank you.
The CCCWFU Research Base is sponsoring a one day intensive training workshop for sites that intend to participate in study # 91105 " A Phase III Double Blind, Placebo Controlled Study of Donepezil in Irradiated Brain Tumor Patients" which is testing a well-tolerated drug used to enhance cognitive performance in brain tumor patients who are >6 months post brain radiation therapy and who meet other study criteria. This one day intensive session will be held on March 25, 2009 on the campus of Wake Forest University Baptist Medical Center in Winston-Salem, NC. There are no fees associated with registration for this session. If you need further information about this training session, please contact Lisa Hawkins at firstname.lastname@example.org.
The following adverse events were reported during the month of February. A PDF of the AE documents has been attached to this email and a summary of the event can be found on the adverse event page of the website.
98308: AEs 8-16 (AE 8 has been amended from the previous version released in February.)
97202: AE 51
In the month of February, 11 patients were accrued to CCCWFU CCOP Research Base trials. Wake Forest was the top accruing site. See the Research Base website home page for accrual information on each site.